𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Treatment of HCV infection with interferon alpha-2b and ribavirin in a patient with X-linked lymphoproliferative syndrome

✍ Scribed by Nicola Strnad-Trojan; Richard Linde; Janine Reichenbach; Jörg Trojan; Stefan Zeuzem; Stefan Zielen

Publisher
Springer
Year
2006
Tongue
English
Weight
89 KB
Volume
165
Category
Article
ISSN
0340-6997

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combined treatment with interferon alpha
Combined treatment with interferon alpha-2b and ribavirin for chronic hepatitis C in patients with a previous non-response or non-sustained response to interferon alone
✍ R. Schvarcz; Z. B. Yun; A. Sönnerborg; O. Weiland 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 442 KB 👁 2 views

Ten patients with chronic hepatitis C, six of whom had not responded and four of whom had responded in a non-sustained fashion to interferon-alpha treatment alone, were given interferon alpha-2b and ribavirin in combination during 24 weeks. Interferon alpha-2b was given subcutaneously, at a dose of

Differential cellular susceptibility to
Differential cellular susceptibility to Epstein-Barr virus infection in a patient with X-linked lymphoproliferative disease
✍ Motohiko Okano; Geoffrey M. Thiele; Thomas G. Gross; Jack R. Davis; David T. Pur 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 925 KB

## Abstract Epstein‐Barr virus (EBV) is often associated with lethal lymphoproliferative disease in immunologically compromised individuals. Recently, we have studied a 20‐month‐old boy with X‐linked lymphoproliferative disease (XLP) who had succumbed to infectious mononucleosis (IM) complicated by